NMO is an autoimmune disorder characterized by severe, recurrent attacks of optic neuritis and transverse myelitis. The presence of AQP4-IgG antibodies is a hallmark of NMO, and their detection is crucial for diagnosis. These antibodies target AQP4, causing inflammatory damage and leading to symptoms such as vision loss, paralysis, and in severe cases, death.
